View Older Stories View More Recent Stories

Oct 27, 2020 08:00AM Twist Bioscience Collaborates With Beyond Earth to Launch Artwork Stored in DNA Into Space
Oct 13, 2020 08:00AM Twist Bioscience to Host Virtual Biopharma Analyst & Investor Event on October 23, 2020
Oct 13, 2020 07:07AM Twist Bioscience Corporation (TWST), Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies
Oct 13, 2020 07:00AM Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies
Sep 18, 2020 08:00AM Emily Leproust, Ph.D., to Receive 2020 Rosalind Franklin Award
Sep 3, 2020 08:00AM Twist Bioscience to Present at Upcoming Virtual Investor Conferences
Sep 2, 2020 08:06AM Twist Bioscience Corporation (TWST) Announces Potent SARS-CoV-2 Neutralizing Data from COVID-19 Therapeutic Antibody Program
Sep 2, 2020 08:00AM Twist Bioscience Announces Potent SARS-CoV-2 Neutralizing Data from COVID-19 Therapeutic Antibody Program
Aug 20, 2020 08:00AM Twist Bioscience Synthetic DNA Stores New Netflix Original Series ‘BIOHACKERS’
Aug 6, 2020 04:05PM Twist Bioscience Reports Third Quarter Fiscal 2020 Financial Results
Aug 4, 2020 08:00AM Seismic Bio Partners With Twist Bioscience for Discovery and Optimization of Antibodies
Jul 30, 2020 08:00AM Twist Bioscience to Report Fiscal 2020 Third Quarter Financial Results on Thursday, August 6, 2020
Jul 28, 2020 08:05AM Twist Bioscience Corporation (TWST) Launches Two SARS-CoV-2 Antibody Panels to Expedite Research for COVID-19
Jul 28, 2020 08:00AM Twist Bioscience Launches Two SARS-CoV-2 Antibody Panels to Expedite Research for COVID-19
Jul 23, 2020 08:00AM Twist Bioscience Appoints Erin Smith Senior Vice President, Government Affairs and Public Policy
Jul 22, 2020 08:00AM Twist Bioscience Launches Synthetic Controls for Respiratory Viruses
Jul 15, 2020 02:28PM Twist Bioscience (TWST) Customer VUMC Announces Publication of Positive Preclinical Results on Neutralizing Antibodies as Potential Therapy for Preventing and Treating COVID-19
Jul 15, 2020 02:20PM Twist Bioscience Customer Vanderbilt University Medical Center (VUMC) Announces Publication of Positive Preclinical Results on Neutralizing Antibodies as a Potential Therapy for Preventing and Treatin
Jul 8, 2020 08:03AM Takeda (TAK) Partners with Twist Bioscience (TWST) to Expand Biologics Discovery Capabilities
Jul 8, 2020 08:00AM Takeda Partners with Twist Bioscience to Expand Biologics Discovery Capabilities
Jun 30, 2020 08:00AM Twist Bioscience Adds Respiratory Virus Panel to Infectious Disease Product Line
Jun 11, 2020 08:02AM Twist Bioscience Corporation (TWST) Announces Expanded Offering of Synthetic SARS-CoV-2 RNA Controls
Jun 11, 2020 08:00AM Twist Bioscience Expands Offering of Synthetic SARS-CoV-2 RNA Controls
Jun 1, 2020 08:00AM Twist Bioscience to Join Proteona in Global Alliance to Protect Immunocompromised Patients From COVID-19 Infection
May 26, 2020 08:00AM Twist Bioscience to Present at the Jefferies Virtual Healthcare Conference
May 12, 2020 08:00AM Twist Bioscience to Participate in the UBS Virtual Global Healthcare Conference
May 7, 2020 04:05PM Twist Bioscience Reports Second Quarter Fiscal 2020 Financial Results
May 6, 2020 08:08AM Twist Bioscience Corporation (TWST) Identifies Competitive Antibodies for SARS-CoV-2
May 6, 2020 08:00AM Twist Bioscience Identifies Competitive Antibodies for SARS-CoV-2
Apr 30, 2020 08:00AM Twist Bioscience to Report Fiscal 2020 Second Quarter Financial Results on Thursday, May 7, 2020
Apr 20, 2020 08:00AM Twist Bioscience Expands Flexibility of Clonal Genes for Pharmaceutical, Biotechnology and Industrial Chemical Research
Mar 26, 2020 08:00AM Twist Bioscience Partners with Vanderbilt University Medical Center to Supply Critical Products and Identify Antibody Therapeutics for COVID-19
Mar 25, 2020 08:14AM Twist Bioscience (TWST) Says its Synthetic SARS-CoV-2 RNA Controls Added to FDA Website as Reference Materials
Mar 25, 2020 08:00AM Twist Bioscience Synthetic SARS-CoV-2 RNA Controls Added to FDA Website as Reference Materials
Mar 16, 2020 08:00AM Twist Announces Availability of Next-Generation Sequencing Target Enrichment Panel for SARS-CoV-2/COVID-19 Research
Mar 12, 2020 08:08AM Twist Bioscience (TWST) Announces Availability of Synthetic SARS-CoV-2 RNA Controls
Mar 12, 2020 08:00AM Twist Bioscience Announces Availability of Synthetic SARS-CoV-2 RNA Controls
Feb 26, 2020 08:05AM Twist Bioscience and SOPHiA GENETICS Collaborate to Offer Optimized Genomic Solutions
Feb 26, 2020 08:00AM Twist Bioscience to Present at the Cowen 40th Annual Health Care Conference
Feb 25, 2020 08:00AM Twist Bioscience and Miroculus Agree to Collaborate on Next-Generation Sequencing Target Enrichment and Library Preparation Tools for Clinical Research
Feb 24, 2020 08:00AM Twist Bioscience Launches New NGS Solutions, Highlights Customers at 2020 Advances in Genome Biology and Technology Conference
Feb 24, 2020 06:00AM GenapSys Partners With Twist Bioscience to Bring Next-Generation Sequencing Target Enrichment and Library Preparation to World’s Most Accessible Highly Accurate Sequencer
Feb 12, 2020 08:00AM Twist Bioscience Now ISO 27001:2013 Certified for Information Security Management System
Feb 6, 2020 04:09PM Twist Bioscience Corporation (TWST) Confirms Settlement with Agilent (A)
Feb 6, 2020 04:05PM Twist Bioscience Reports First Quarter Fiscal 2020 Financial Results
Feb 6, 2020 04:04PM Twist Bioscience Announces Settlement Agreement with Agilent
Jan 31, 2020 04:18PM CORRECTING and REPLACING Twist Bioscience Announces Completion of $50 Million Offering Priced At-The-Market
Jan 27, 2020 08:12AM Twist Bioscience Corporation (TWST) Announces Completion of $50 Million Registered Direct Offering of Common Stock
Jan 27, 2020 08:00AM Twist Bioscience Announces Completion of $50 Million Registered Direct Offering Priced At-The-Market
Jan 23, 2020 08:00AM Twist Bioscience to Report Fiscal 2020 First Quarter Financial Results on Thursday, February 6, 2020
View More Recent Stories View Older Stories